| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 49 |
| 1 | ADALIMUMAB | 32 |
| 2 | METHOTREXATE SODIUM | 20 |
| 3 | ETANERCEPT | 18 |
| 4 | METHOTREXATE | 18 |
| 5 | ARIPIPRAZOLE | 16 |
| 6 | ACETAMINOPHEN | 13 |
| 7 | ALPRAZOLAM | 13 |
| 8 | ADALIMUMAB-AATY | 12 |
| 9 | ADALIMUMAB-ADAZ | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM-BMEZ | 2 | 0.0033 |
| 1 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 2 | 2%MENTHOL | 2 | 0.0019 |
| 3 | COUGH SUPPRESSANT | 2 | 0.0019 |
| 4 | GARADACIMAB | 1 | 0.0013 |
| 5 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 6 | FINASTERIDE | 49 | 0.0008 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 8 | DROPERIDOL | 1 | 0.0006 |
| 9 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 50 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 42 |
| 2 | Benzodiazepine [EPC] | 29 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 4 | Atypical Antipsychotic [EPC] | 25 |
| 5 | Corticosteroid [EPC] | 20 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 8 | Vitamin B12 [EPC] | 13 |
| 9 | Vitamin C [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 50 | 0.0005 |
| 3 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Typical Antipsychotic [EPC] | 6 | 0.0002 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 8 | Stimulant Laxative [EPC] | 3 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |